
Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc (CURX)
WebsitePrice
Market cap
Next catalystPhase 1 clinical development planned to initiate in Australia in Q4 2026, subject to completion of required studies and regulatory clearancePhyto-N — ulcerative colitis · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
PreINDP2P3FilingApproved